ResMed, Inc. (RMD)
218.89
-2.26
(-1.02%)
USD |
NYSE |
Oct 02, 16:00
219.04
+0.14
(+0.07%)
After-Hours: 20:00
ResMed Price : 218.89 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 221.66 | 223.73 | 218.03 | 218.89 | 898888.0 |
| Oct 01, 2026 | 220.75 | 224.14 | 219.00 | 221.15 | 930419.0 |
| Sep 30, 2026 | 222.63 | 224.04 | 220.00 | 221.10 | 1.308M |
| Sep 29, 2026 | 221.96 | 224.22 | 220.32 | 222.83 | 949403.0 |
| Sep 28, 2026 | 221.52 | 223.00 | 218.26 | 222.10 | 862828.0 |
| Sep 25, 2026 | 221.08 | 223.22 | 220.13 | 222.00 | 760793.0 |
| Sep 24, 2026 | 223.08 | 224.50 | 220.38 | 221.89 | 798773.0 |
| Sep 23, 2026 | 222.78 | 225.10 | 220.00 | 222.30 | 1.440M |
| Sep 22, 2026 | 226.22 | 227.90 | 221.82 | 221.97 | 1.031M |
| Sep 21, 2026 | 225.16 | 226.52 | 223.34 | 223.61 | 1.072M |
| Sep 18, 2026 | 228.21 | 228.38 | 224.56 | 224.99 | 3.862M |
| Sep 17, 2026 | 228.25 | 229.57 | 225.08 | 228.42 | 1.086M |
| Sep 16, 2026 | 228.19 | 229.32 | 224.26 | 228.25 | 1.067M |
| Sep 15, 2026 | 226.36 | 234.33 | 225.12 | 229.44 | 1.641M |
| Sep 14, 2026 | 221.04 | 225.82 | 220.94 | 222.99 | 989011.0 |
| Sep 11, 2026 | 220.44 | 221.29 | 215.97 | 218.27 | 912333.0 |
| Sep 10, 2026 | 217.93 | 221.25 | 215.80 | 219.58 | 923145.0 |
| Sep 09, 2026 | 220.84 | 220.84 | 217.00 | 219.95 | 1.200M |
| Sep 08, 2026 | 226.22 | 226.66 | 220.44 | 221.05 | 1.959M |
| Sep 04, 2026 | 225.91 | 228.49 | 225.12 | 228.35 | 843837.0 |
| Sep 03, 2026 | 231.20 | 233.04 | 227.26 | 229.19 | 1.483M |
| Sep 02, 2026 | 234.73 | 237.21 | 230.78 | 230.87 | 1.156M |
| Sep 01, 2026 | 239.90 | 242.40 | 230.18 | 231.36 | 987078.0 |
| Aug 31, 2026 | 237.97 | 241.71 | 236.16 | 240.10 | 1.722M |
| Aug 28, 2026 | 236.64 | 241.06 | 235.01 | 240.33 | 1.387M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| IDEXX Laboratories, Inc. | 518.39 |
| Accuray, Inc. | 0.281 |
| Micron Solutions, Inc. | 0.0512 |
| Eli Lilly & Co. | 1142.85 |
| Neogen Corp. | 12.15 |
Price Related Metrics
| PE Ratio | 20.97 |
| PS Ratio | 5.652 |
| PEG Ratio | 2.15 |
| Price to Book Value | 4.794 |
| Price to Free Cash Flow | 19.62 |
| Earnings Yield | 4.77% |
| Market Cap | 31.57B |
| PEGY Ratio | 1.928 |
| Operating PE Ratio | 16.62 |
| Normalized PE Ratio | 20.82 |